Back
SPDR Bloomberg 1-3 Month T-Bill ETF Vs. Novo Nordisk AS Industry Stock Comparison
Sell
7
BIL
SPDR Bloomberg 1-3 Month T-Bill ETF
Last Price:
$91.47
Seasonality Move:
0.04%
Sell
11
NONOF
Novo Nordisk AS
Last Price:
$87.25
Seasonality Move:
8.64%
Sell
7
SPDR Bloomberg 1-3 Month T-Bill ETF (BIL)
is a Sell
Is SPDR Bloomberg 1-3 Month T-Bill ETF a Buy, Sell or Hold?
-
The current SPDR Bloomberg 1-3 Month T-Bill ETF [BIL] share price is $91.46. The Score for BIL is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
-
BIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
11
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.25. The Score for NONOF is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
BIL Stock Price Chart
What is SPDR Bloomberg 1-3 Month T-Bill ETF's stock price today?
-
The SPDR Bloomberg 1-3 Month T-Bill ETF share price today is $91.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIL is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
BIL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 45.43 | Sell |
Chaikin Money Flow: | -7837946 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.4 - 91.66) | Sell |
Bollinger Bands (100): | (91.49 - 91.73) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.11 | Sell |
Relative Strength Index (14 RSI): | 32.46 | Sell |
Chaikin Money Flow: | -24249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.97 - 111.39) | Sell |
Bollinger Bands (100): | (101.47 - 130.27) | Sell |
BIL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.4 | Buy |
20-day SMA: | 91.5 | Sell |
50-day SMA: | 91.59 | Sell |
200-day SMA: | 91.61 | Sell |
8-day EMA: | 91.44 | Buy |
20-day EMA: | 91.49 | Sell |
50-day EMA: | 91.55 | Sell |
200-day EMA: | 91.6 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.94 | Buy |
20-day SMA: | 98.73 | Sell |
50-day SMA: | 104.27 | Sell |
200-day SMA: | 124.31 | Sell |
8-day EMA: | 88.93 | Sell |
20-day EMA: | 95.33 | Sell |
50-day EMA: | 103.73 | Sell |
200-day EMA: | 115.63 | Sell |
SPDR Bloomberg 1-3 Month T-Bill ETF Earnings Growth & BIL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
SPDR Bloomberg 1-3 Month T-Bill ETF Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |